NASDAQ:EPIX - ESSA Pharma Inc.
$3.63
 $0.02
+0.69%
2:10PM EDT
2019-02-15
ESSA Pharma Inc. is a Canada-based clinical-stage development pharmaceutical company. The Company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer (CRPC). The Company is developing drugs, which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR). The Company's product candidate, EPI-506 is a selective, oral small molecule pro-drug that blocks the N-terminal domain of the AR. EPI-506 is a pro-drug of EPI-002, a stereoisomer of the Company's discovery compound, EPI-001. The Company is conducting a Phase I/II clinical study to determine the safety, tolerability, maximum tolerated dose, pharmacokinetics and efficacy of EPI-506 in patients with metastatic CRPC. It is focused on developing EPI-506 as its clinical-development product candidate. ESSA Pharmaceuticals Corp. is the Company's subsidiary. The Company has not generated any revenues. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  EPIX     avg for
industry  
  avg for
sector  
42 stocks weight:  -1000. 00   0. 00   0. 00  
42 stocks rank:  4. 05 K 1. 86 K 1. 09 K

quick ratio:  4. 52   5. 37   1. 81  
current ratio:  4. 66   5. 69   2. 19  

1-yr high:  4. 74   124. 30   142. 77  
last close:  3. 61   101. 85   127. 84  
50-day avg:  3. 10   98. 27   122. 46  
200-day avg:  3. 34   99. 72   122. 70  
1-yr low:  0. 16   78. 19   100. 16  
volume:  20. 93 K 2. 38 M 4. 64 M
50-day avg volume:  7. 90 K 3. 31 M 4. 94 M
200-day avg volume:  11. 04 K 3. 23 M 4. 28 M

1-day return:  -3. 73 % 0. 22 % 0. 48 %
this week return:  -5. 50 % 1. 77 % 2. 01 %
12-wk return:  38. 31 % 6. 56 % 3. 33 %
52-wk return:  1714. 29 % -2. 23 % 14. 35 %

enterprise value (EV):  15. 53 M 55. 17 B 104. 51 B
market cap:  22. 56 M 49. 01 B 96. 46 B
EBITDA:  -10. 77 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -1. 44   -91. 79   2. 29  
total debt:  6. 32 M 13. 73 B 16. 57 B
debt/equity:  69. 02   258. 01   110. 73  
net income (common):  -11. 63 M 2. 37 B 3. 58 B

shares outstanding:  5. 78 M 607. 99 M 1. 22 B
shares:  2. 27 M 605. 53 M 1. 15 B
shares short:  11. 97 K 11. 62 M 12. 55 M
shares short prior month:  1. 58 K 11. 95 M 13. 44 M
short ratio:  1. 94   4. 82   3. 10  
short % of float:  0. 39 % 6. 19 % 2. 82 %
total cash/share:  2. 35   12. 02   11. 46  
total cash:  14. 83 M 7. 41 B 7. 37 B
free cash flow:  -6. 75 M 95. 99 M 2. 04 B
operating cash flow:  -10. 22 M 164. 74 M 3. 04 B

book value:  1. 58   14. 43   28. 26  
price/book:  2. 28   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  29. 16 % --- ---
1-yr mean volatility:  0. 15 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 55   3. 03   4. 09  
P/E:  -1. 42   6. 11   26. 91  
PE/G:  0. 07   0. 37   5. 61  
growth:  -20. 39 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -62. 44 % -3. 27 % 3. 81 %
return on equity:  -476. 80 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  1. 28   1. 21   0. 93  
sharpe (1yr):  0. 37   0. 06   0. 98  


Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : EPIX
.        + 0 =             0 :: INITIAL WEIGHT
.  + 732.317 =       732.317 :: inverse volume-to-price addition
.  + 190.859 =       923.176 :: spline projection addition
.  - 186.917 =       736.259 :: poor performance penalty
.    x 2.887 =      2125.366 :: 13 weeks' performance factor
.    x 1.492 =      3172.086 :: industry recommendation factor
.    x 0.994 =      3152.279 :: return on assets factor
.    x 0.952 =      3001.976 :: return on equity factor
.    x 2.819 =      8463.083 :: current ratio factor
.    x 1.133 =       9589.27 :: quick ratio factor
.    x 1.231 =     11804.793 :: short ratio factor
.    x 2.023 =     23878.622 :: price-to-book factor
.    x 1.126 =     26883.501 :: debt-to-equity factor
.    x 1.123 =     30182.577 :: 5-day avg > 200-day avg
.     x 1.21 =      36514.48 :: 5-day avg > 50-day avg
.    x 2.168 =     79175.266 :: P/E weight
.    x 1.947 =    154187.697 :: PE/G factor
.    x 1.708 =    263417.345 :: beta factor
.    x 0.369 =      97181.55 :: sharpe factor
.    x 1.066 =    103557.904 :: industry 12-weeks return
.    x 0.996 =    103133.294 :: overall "drift" factor
.    x 0.708 =     73064.468 :: largest single-day jump factor
.    x 0.074 =      5384.264 :: low price factor
.      x 1.0 =      5384.626 :: factor hist industry gain for week 06
.           0.0 symbols[symbol]['1Ygain'] > 4.2
.                   -999.999 :: FINAL WEIGHT for NASDAQ:EPIX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org